J&J created LTL Management in 2021 to handle the lawsuits, which hover at about 40,000, that allege its talc-based baby powder posed a cancer risk but didn’t inform customers of it. LTL’s strategy is to bankrupt itself under Chapter 11, which would then protect J&J at large, but the case’s Texas judges are expected to dissect this plan, according to the Journal.
Chapter 11 is a bankruptcy code that lets debtors who can’t pay off debts reorganize its business and debt structure, according to Cornell Law School’s Legal Information Institute.
Without LTL acting as a shield, the business said legal costs would surpass $1 billion, which would stack on top of the billions it already shelled out in other talc lawsuits, according to the Journal. One of its biggest payments happened in 2020 when a different appellate court ordered the pharmaceutical company to award more than $2 billion to women with ovarian cancer.
The Texas appellate court decision on whether to allow the subsidiary to use Chapter 11 could act as a precedent for future similar cases between drug companies and consumers.
Editor’s note: The headline was revised 12:00 p.m. CT to specify LTL Management, not J&J, is planning on bankruptcy.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
